Fundamental Analysis
15 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -18.0% | -24.6% | 1 / 3 | +2.6% | -0.06 pp | -0.22 pp | +11.7% | 1.77 | 5.41 | 1.718 | +2,6% | 15,1 | −18,0% | 5.41 | 4.81 | +12,5% |
| Pts | 0 | 0 | 4 | 0 | 4 | 4 | 0 | -4 | 8 | |||||||
Valuation annotation:Price: 9.100 (close price on 2026-10-19)EPS (TTM): 1.682
Financial charts
1.Revenue & growth
VND bn1.718Q2/26
1.Revenue & growth
VND bn1.718Q2/26
2.Profit & growth
VND bn15,1Q2/26
3.Profit mix (Penman)
VND bn95,7Q2/26
4.Margins & cost structure
%5.6%Q2/26
5.Returns & cash cycle
% · days7.9%Q2/26
6.Earnings quality & cash
VND bn213Q2/26
7.Asset structure
VND bn2.621Q2/26
8.Funding & debt health
VND bn · times2.621Q2/26
9.Revenue backlog
VND bn0,00Q2/26
10.Valuation
times · %5,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %336Q2/26
Adjusted EPS growth, latest quarter
-18.0%
Average adjusted EPS growth, 3 quarters
-24.6%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26